BostonGene Overview
Pro stress-test →BostonGene redefines cancer patient care and drug development through the integration of omnimodal data and AI. Built and validated through an extensive real-world clinical testing network, BostonGene's Foundation Model of cancer and the immune system integrates genomic, transcriptomic, and immune data with clinical outcomes to generate biologically grounded, actionable insights.
Strategic Profile
Pro stress-test →BostonGene has established unrivaled credibility across oncology and immunology through a collaborative ecosystem of deep academic partnerships with MD Anderson Cancer Center, Memorial Sloan Kettering, Dana Farber Cancer Institute, the Mayo Clinic, and other leading cancer institutions across the globe. These are complemented by strategic business partnerships with AstraZeneca, Johnson & Johnson, Takeda, Ottimo Pharma, and other global pharma and biotech leaders. The company's industry-leading innovation has been recognized with awards such as Frost & Sullivan's 2025 Global Technology Innovation Leadership Award in AI-driven Precision Oncology Solutions, as well as BioTech Breakthrough's 2025 Overall Immunology Company of the Year and 2025 AI-based Drug Discovery Solution of the Year.
Competitive Landscape
Pro stress-test →Strata Oncology develops biomarkers for cancer treatment, offering tools that analyze tumor biology to predict patient response to therapies, serving the biopharmaceutical sector and based in Ann Arbor, Michigan since 2015. SimBioSys provides visualization and diagnostic technology aimed at addressing clinical questions in cancer care with cloud-based tools and AI solutions, based in Chicago, Illinois since 2018. BostonGene differentiates through its comprehensive Foundation Model, elite institutional networks, and multi-omics integration across genomics, transcriptomics, and immune profiling.
Industry Context
BostonGene operates in Precision Oncology / AI-Driven Biomarker Discovery.
Key facts
Founded: 2015 · Headquarters: Waltham, Massachusetts, US · Employees: N/A · Revenue: N/A · Market cap: N/A